Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT01955577
Other study ID # N-20130033
Secondary ID
Status Not yet recruiting
Phase Phase 1
First received September 24, 2013
Last updated April 9, 2015
Start date April 2015
Est. completion date December 2016

Study information

Verified date April 2015
Source Northern Orthopaedic Division, Denmark
Contact Christian Cavallius, M.D.
Email christian.cavallius@rn.dk
Is FDA regulated No
Health authority Denmark: The Danish National Committee on Biomedical Research EthicsDenmark: Danish Dataprotection Agency
Study type Interventional

Clinical Trial Summary

The purpose is to study:

1. the frequency of vitamin D deficiency at patients with tibial fracture treated with an external ring fixator

2. if vitamin D supplement facilitates fracture healing

3. a possible relation between vitamin D deficiency and the risk of complications and the time of fracture healing


Description:

External ring fixator is a widespread and well-known method to treate complex tibial fractures. The effect of treating proximal and distal intra-articulatio tibial fractures has been positive until now.

Complications such as malunions, nonunions, re-fractures and extended time of ring fixation will occur in 5-10% of all tibial fractures in patients treated with ring fixator. Factors like trauma of soft tissue, smoking and compromised afflux of blood are associated with a higher frequency of nonunion.

It has been documented that elderly people with hypovitaminosis D have a higher risk of being affected by osteoporosis and fractures. Furthermore, there is a possible association between the severity of fracture and hypovitaminosis. The time of fracture healing is also extended compared to fractures in patients who are not affected by osteoporosis.

Until now research has not shown whether the fracture healing process is influenzed by vitamin D.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 130
Est. completion date December 2016
Est. primary completion date December 2015
Accepts healthy volunteers No
Gender Both
Age group 18 Years to 90 Years
Eligibility Inclusion Criteria:

- Patients with tibial fracture

- A written signed statement of consent

- All potential patients primary with osteosynthesis Iliazov

Exclusion Criteria:

- Tumours in bone

- Metastases to bone marrow

- Chronic renal disease

- Drug abuse

- Abuse of alcohol (>21 drinks a week for men and > 14 drinks a week for women)

- Morbus Cushing disease

- Glandulae thyroid disease

- Pregnancy

- Chronic steroid therapy

- Hepatic insufficiency

- Sarcoidosis, tuberculosis or silocosis

- Patients under 18 years

- Inability to take medicine

- Adverse effects of vitamin D or allergic to vitamin D

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Drug:
Placebo orally everyday

Vitamin D3 cholecalciferol


Locations

Country Name City State
Denmark Aalborg University Hospital Aalborg Region Northern Jutland

Sponsors (1)

Lead Sponsor Collaborator
Northern Orthopaedic Division, Denmark

Country where clinical trial is conducted

Denmark, 

Outcome

Type Measure Description Time frame Safety issue
Primary Time of fracture healing Time of fracture healing, i.e. time from osteosynthesis until fracture healing is clinically and radiologically registered. 20 weeks No
Secondary Vitamin D receptor DNA A DNA blood sample will be taken in order to analyse how the skeleton reacts on vitamin D supplement. 20 weeks No
Secondary Complications Registration of possible complications, i.e. nonunion, malunion, number of check-ups, infections, re-surgery. 20 weeks No
See also
  Status Clinical Trial Phase
Terminated NCT01927575 - Pilot Study Comparing Diagnostic Imaging Versus Tomosynthesis in Detection of Hip, Wrist or Tibia Injury N/A
Completed NCT01017094 - Pin Site Infection Prevention for Open Tibial Fracture Phase 3
Completed NCT00038129 - SPRINT - Randomized Trial of Tibial Fracture Fixation N/A
Recruiting NCT01795287 - Safety of Spinal Anesthesia in Patients With Tibial Shaft Fracture N/A
Terminated NCT01300520 - The Development of a Surgical Localizing Aid Medical Device N/A
Active, not recruiting NCT05012449 - Transitional Ankle Fracture Management Using a New Joystick Technique N/A
Recruiting NCT04432389 - Study to Assess the Efficacy and Safety of Allogeneic Osteoblastic Cells (ALLOB®) Single Implantation in Tibial Fracture Phase 2
Suspended NCT00365573 - Doppler Ultrasonography Evaluation of Tibial Fracture Site Vascularity Phase 2
Completed NCT02820363 - Study Evaluating CERAMENTâ„¢|G in Open Diaphyseal Tibial Fractures N/A
Completed NCT00264511 - Hyperbaric Oxygen in Lower Leg Trauma Phase 2/Phase 3
Completed NCT04028908 - Remodelling After Trampoline Fracture in Children
Completed NCT02140528 - Allogeneic Mesenchymal Stem Cell Transplantation in Tibial Closed Diaphyseal Fractures Phase 2
Active, not recruiting NCT03598530 - Fracture-Related Outcome Study for Operatively Treated Tibia Shaft Fractures
Completed NCT00250302 - Autologous Implantation of Mesenchymal Stem Cells for the Treatment of Distal Tibial Fractures Phase 1/Phase 2
Unknown status NCT02035917 - Comparison of Tibial Plateau Fractures Outcomes Treated With Non-locking and Locking Plate N/A